Lactoperoxidase-catalyzed oxidation of the anticancer agent mitoxantrone by nitrogen dioxide (NO2·) Radicals

Chemical Research in Toxicology

Volumn 10, Issue 12, 1997, Pages 1325-1330

  Reszka, Krzysztof J ^a   Matuszak, Zenon ^a,b   Chignell, Colin F ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROGEN PEROXIDE; LACTOPEROXIDASE; MITOXANTRONE; NITROGEN DIOXIDE; RADICAL; SODIUM NITRITE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CATALYSIS; DRUG ACTIVATION; DRUG CYTOTOXICITY; DRUG OXIDATION; LEUKEMIA;

ANIMALS; ANTINEOPLASTIC AGENTS; FREE RADICALS; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; LACTOPEROXIDASE; MITOXANTRONE; NITRATES; NITROGEN DIOXIDE; OXIDATION-REDUCTION; SPECTROMETRY, FLUORESCENCE;

MAMMALIA;

EID: 0031473114     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970039q     Document Type: Article

References (43)

1. Smith, I. E. (1983) Mitoxantrone (novantrone): A review of experimental and early clinical studies. Cancer Treat. Rev. 10, 103-115.
2. Faulds, D., Balfour, J. A., Chrisp, P., and Langtry, H. D. (1991) Mitoxantrone. A review of its pharmacodynamic and pharmaceutic properties, and therapeutic potential in the chemotherapy of cancer. Drugs 41, 400-449.
3. Polverini, P. J., and Novak, R. F. (1986) Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene. Biochem. Biophys. Res. Commun. 140, 901-907.
4. Iigo, M., Shimamura, M., Sagawa, K., and Tsuda, H. (1995) Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26. Jpn. J. Cancer Res. 86, 867-872.
5. Karasch, E. D., and Novak, R. F. (1983) Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation. J. Pharmacol. Exp. Ther. 226, 500-506.
6. Kharasch, E. D., and Novak, R. F. (1985) Mitoxantrone and ametantrone inhibit hydroperoxide-dependent initiation and propagation reactions in fatty acid peroxidation. J. Biol. Chem. 260, 10645-10652.
7. Frank, P., and Novak, R. F. (1985) Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro. Biochem. Pharmacol. 34, 3609-3614.
8. Mewes, K., Blanz, J., Ehninger, G., Gebhardt, R., and Zeller, K.-P. (1993) Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates. Cancer Res. 53, 5135-5142.
9. Mewes, K., Blanz, J., Freund, S., Ehninger, G., and Zeller, K.-P. (1994) Synthesis and structural elucidation of biliary excreted thioether derivatives of mitoxantrone. Xenobiotica 24, 199-213.
10. 14C-labeled drug. Biochem. Pharmacol. 38, 4253-4260.
11. Fisher, G. R., and Patterson, L. H. (1990) DNA strand breakage by peroxidase-activated mitoxantrone. J. Pharm. Pharmacol. 43, 65-68.
12. Panousis, C., Kettle, A. J., and Phillips, D. R. (1995) Myeloperoxidase oxidizes mitoxantrone to metabolites which bind covalently to DNA and RNA. Anti-Cancer Drug Des. 10, 593-605.
13. 32P-Postlabeling analysis of adducts formed by mitoxantrone and ametantrone with DNA and homopolydeoxyribonucleotides after enzymatic activation. Chem.-Biol. Interact. 98, 153-166.
14. Reszka, K., Kolodziejczyk, P., and Lown, J. W. (1986) Horseradish peroxidase-catalyzed oxidation of mitoxantrone: Spectrophotometric and electron paramagnetic resonance studies. J. Free Radicals Biol. Med. 2, 25-32.
15. Kolodziejczyk, P., Reszka, K., and Lown, J. W. (1988) Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone. Free Radical Biol. Med. 5, 13-25.
16. Reszka, K. J., and Chignell, C. F. (1996) Acid-catalyzed oxidation of the anticancer agent mitoxantrone by nitrite ions. Mol. Pharmacol. 50, 1612-1618.
17. Chance, B. (1952) The kinetics and stoichiometry of the transition from the primary to the secondary peroxidase peroxide complexes. Arch. Biochem. Biophys. 41, 416-424.
18. Roman, R., and Dunford, H. B. (1973) Studies on horseradish peroxidase. XII. A kinetic study of the oxidation of sulfite and nitrite by compounds I and II. Can. J. Chem. 51, 588-596.
19. Kohler, H., and Jenzer, H. (1989) Interaction of lactoperoxidase with hydrogen peroxide. Free Radical Biol. Med. 6, 323-339.
20. Shibata, H., Kono, Y., Yamashita, S., Sawa, Y., Ochiai, H., and Tanaka, K. (1995) Degradation of chlorophyll by nitrogen dioxide generated from nitrite by the peroxidase reaction. Biochim. Biohys. Acta 1230, 45-50.
21. Van der Vliet, A., Eiserich, J. P., Halliwell, B., and Cross, C. E. (1997) Formation of reactive nitrogen species during peroxidasecatalyzed oxidation of nitrite. J. Biol. Chem. 272, 7617-7625.
22. Paul, K.-G., and Ohlsson, P.-I. (1985) The chemical structure of lactoperoxidase. In The Lactoperoxidase System. Chemistry and Biological Significance (Pruitt, K. M., and Tenovuo, J. O., Eds.) pp 15-29, Mercel Dekker Inc., New York.
23. Kapuscinski, J., Darzynkiewicz, Z., Traganos, F., and Melamed, M. R. (1981) Interactions of a new antitumor agent, 1,4-dihydroxy- 5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione, with nucleic acids. Biochem. Pharmacol. 30, 231-240.
24. Kapuscinski, J., and Darzynkiewicz, Z. (1985) Interactions of antitumor agents Ametantrone and mitoxantrone (Novantrone) with double-stranded DNA. Biochem. Pharmacol. 34, 4203-4213.
25. Kharasch, E. D., and Novak, R. F. (1984) Spectroscopic evidence for anthracenedione antineoplastic agent self-association and complex formation with flavin nucleotides. Arch. Biochem. Biophys. 234, 497-512.
26. Lee, B. S., and Dutta, P. K. (1989) Optical spectroscopic studies of the antitumor drug 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)-amino]ethyl]amino]-9,10-anthracene- dione (Mitoxantrone). J. Phys. Chem. 93, 5665-5672.
27. Hu, S., Treat, R. W., and Kincaid, J. R. (1993) Distinct heme active-site structure in lactoperoxidase revealed by resonance Raman spectroscopy. Biochemistry 32, 10125-10130.
28. Panousis, C., Kettle, A. J., and Phillips, D. R. (1994) Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase. Biochem. Pharamcol. 48, 2223-2230.
29. Ebbing, D. D. (1990) General Chemistry, 3rd ed., Houghton Mifflin Co., Boston.
30. Dunford, B. H. (1995) One-electron oxidations by peroxidases. Xenobiotica 25, 725-733.
31. Klebanow, S. J. (1993) Reactive nitrogen intermediates and antimicrobial activity: Role of nitrite. Free Radical Biol. Med. 14, 351-360.
32. . in aqueous solution. Z. Naturforsch. 39C, 725-727.
33. .. Toxicology 89, 193-216.
34. Kikugawa, K., Kato, T., and Okamoto, Y. (1994) Damage of amino acids and proteins induced by nitrogen dioxide, a free radical toxin, in air. Free Radical Biol. Med. 16, 373-382.
35. Prutz, W. A., Monig, H., Butler, J., and Land E. J. (1985) Reactions of nitrogen dioxide in aqueous model systems: Oxidation of tyrosine units in peptides and proteins. Arch. Biochem. Biophys. 243, 125-134.
36. Halliwell, B., Hu, M.-L., Louie, S., Duvall, T. R., Tarkington, B. K., Motchnik, P., and Cross, C. E. (1992) Interaction of nitrogen dioxide with human plasma. FEBS Lett. 313, 62-66.
37. Lewis, R. S., and Deen, W. M. (1994) Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem. Res. Toxicol. 7, 568-574.
38. Nathan, C. F., and Hibbs, J. B., Jr. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70.
39. Moncada, S., and Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012.
40. Hibbs, J. B., Jr., Taintor, R. R., Vavrin, Z., and Rachlin, E. M. (1988) Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87-94.
41. Stuehr, D. J., and Nathan, C. F. (1989) Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1545.
42. Darley-Usmar, V., Wiseman, H., and Halliwell, B. (1995) Nitric oxide and oxygen radicals: A question of balance. FEBS Lett. 369, 131-135.
43. Darley-Usmar, V., and Halliwell, B. (1996) Blood radicals. Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharmacol. Res. 13, 649-662.